Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; STREAM Investigative Team. Armstrong PW, et al. Among authors: grajek s. N Engl J Med. 2013 Apr 11;368(15):1379-87. doi: 10.1056/NEJMoa1301092. Epub 2013 Mar 10. N Engl J Med. 2013. PMID: 23473396 Free article. Clinical Trial.
Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry).
Grajek S, Lesiak M, Araszkiewicz A, Pyda M, Skorupski W, Grygier M, Mitkowski P, Prech M, Baszko A, Janus M, Breborowicz P, Rzeźniczak J, Tarchalski J, Główka A, Cieśliński A. Grajek S, et al. Kardiol Pol. 2008 Feb;66(2):154-63; discussion 164-5. Kardiol Pol. 2008. PMID: 18344153 Clinical Trial.
Effect of a combination of antiplatelet and antithrombotic pretreatment on myocardial perfusion in patients with an acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Prech M, Bartela E, Janus M, Jeremicz I, Araszkiewicz A, Urbanska L, Pyda M, Grajek S. Prech M, et al. Among authors: grajek s. Coron Artery Dis. 2016 Nov;27(7):580-5. doi: 10.1097/MCA.0000000000000394. Coron Artery Dis. 2016. PMID: 27228184
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
Delewi R, Hirsch A, Tijssen JG, Schächinger V, Wojakowski W, Roncalli J, Aakhus S, Erbs S, Assmus B, Tendera M, Goekmen Turan R, Corti R, Henry T, Lemarchand P, Lunde K, Cao F, Huikuri HV, Sürder D, Simari RD, Janssens S, Wollert KC, Plewka M, Grajek S, Traverse JH, Zijlstra F, Piek JJ. Delewi R, et al. Among authors: grajek s. Eur Heart J. 2014 Apr;35(15):989-98. doi: 10.1093/eurheartj/eht372. Epub 2013 Sep 11. Eur Heart J. 2014. PMID: 24026778 Free PMC article. Review.
Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
Pyda M, Korybalska K, Ksiazek K, Grajek S, Lanocha M, Lesiak M, Wiśniewska-Elnur J, Olasińska A, Breborowicz A, Cieśliński A, Witowski J. Pyda M, et al. Among authors: grajek s. Am J Cardiol. 2006 Oct 1;98(7):902-5. doi: 10.1016/j.amjcard.2006.04.028. Epub 2006 Aug 7. Am J Cardiol. 2006. PMID: 16996870
276 results